{"log_id": 8005095459049147725, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 0.011396, "average": 0.941032, "min": 0.643295}, "location": {"width": 135, "top": 209, "height": 24, "left": 244}, "words": "常综合征(MDS)"}, {"probability": {"variance": 0.001445, "average": 0.986679, "min": 0.836586}, "location": {"width": 323, "top": 245, "height": 29, "left": 286}, "words": "2)有极少数患者缺乏氟尿嘧啶代谢酶"}, {"probability": {"variance": 0.000105, "average": 0.996358, "min": 0.94791}, "location": {"width": 440, "top": 238, "height": 31, "left": 663}, "words": "氢嘧啶脱氢酶(DPD),若使用氟尿嘧啶类药物,则在"}, {"probability": {"variance": 0.000569, "average": 0.994008, "min": 0.862153}, "location": {"width": 617, "top": 281, "height": 36, "left": 242}, "words": "给药初期可能出现严重不良反应(如口腔炎、腹泻、造血功能异常和神经"}, {"probability": {"variance": 3.6e-05, "average": 0.99657, "min": 0.970361}, "location": {"width": 481, "top": 322, "height": 34, "left": 285}, "words": "3)曾发现脑梗死,但与替吉奥胶囊的因果关系并不确定"}, {"probability": {"variance": 0.032991, "average": 0.570184, "min": 0.38855}, "location": {"width": 175, "top": 286, "height": 103, "left": 795}, "words": "药"}, {"probability": {"variance": 0.003369, "average": 0.978026, "min": 0.70558}, "location": {"width": 819, "top": 357, "height": 41, "left": 285}, "words": "4)奥替拉西钾在强酸环境下易分解(犬),而奥替拉西钾的浓度降低可减弱其制消化道不良反应"}, {"probability": {"variance": 2.2e-05, "average": 0.996401, "min": 0.980141}, "location": {"width": 461, "top": 402, "height": 37, "left": 245}, "words": "的作用(大鼠),故胃pH值明显降低时有可能导致腹泻"}, {"probability": {"variance": 0.000116, "average": 0.994483, "min": 0.946286}, "location": {"width": 482, "top": 443, "height": 34, "left": 285}, "words": "()犬反复给药后曾发现球结膜巩膜色素沉着和角膜云翳"}, {"probability": {"variance": 1e-06, "average": 0.998432, "min": 0.996197}, "location": {"width": 159, "top": 527, "height": 25, "left": 246}, "words": "二、国内临床试验"}, {"probability": {"variance": 0.00684, "average": 0.981699, "min": 0.432332}, "location": {"width": 810, "top": 557, "height": 38, "left": 288}, "words": "一项由日本大鹏药业株式会社发起中国15个研究中心参加的随机对照多中心临床研究中(SC101"}, {"probability": {"variance": 4.5e-05, "average": 0.994986, "min": 0.97579}, "location": {"width": 845, "top": 598, "height": 38, "left": 249}, "words": "试验),230例晚期胃癌患者随机接受替吉奥胶囊单药或替吉奥胶囊联合顺铂方案[详见【临床试验】]"}, {"probability": {"variance": 7.7e-05, "average": 0.99623, "min": 0.949876}, "location": {"width": 856, "top": 639, "height": 37, "left": 248}, "words": "中,所出现的不良反应均是在日本报告的已知不良反应。CTC≥3度的不良反应发生率如下:替吉奥"}, {"probability": {"variance": 0.001366, "average": 0.990406, "min": 0.77165}, "location": {"width": 856, "top": 679, "height": 39, "left": 246}, "words": "联合顺铂组的血液学不良反应包括:贫血5.3%、粒细胞减少5.3%、红细胞压积降低2.6%、血红蛋白"}, {"probability": {"variance": 0.000539, "average": 0.992796, "min": 0.84086}, "location": {"width": 839, "top": 721, "height": 36, "left": 247}, "words": "降低10.5%、淋巴细胞减少5.3%、嗜中性粒细胞减少17.1%、血小板减少6.6%、红细胞减少2.6%"}, {"probability": {"variance": 0.004461, "average": 0.978576, "min": 0.562688}, "location": {"width": 856, "top": 761, "height": 38, "left": 249}, "words": "白细胞减少13.2%、AST升高1.3%、LDH升高1.3%、BUN升高1.3%;非血液学不良反应包括:腹"}, {"probability": {"variance": 0.00401, "average": 0.979293, "min": 0.666649}, "location": {"width": 785, "top": 801, "height": 40, "left": 248}, "words": "泻6.6%、恶心2.6%、呕吐6.6%、肠炎1.3%、肝功能异常2.6%、过敏1.3%、肺部感染13%"}, {"probability": {"variance": 0.000786, "average": 0.990459, "min": 0.838342}, "location": {"width": 817, "top": 842, "height": 37, "left": 288}, "words": "替吉奥单药组的血液学不良反应包括:贫血2.5%、血红蛋白降低6.3%、淋巴细胞减少8.8%、嗜"}, {"probability": {"variance": 0.001684, "average": 0.985213, "min": 0.794483}, "location": {"width": 842, "top": 883, "height": 37, "left": 249}, "words": "中性粒细胞减少3.8%、白细胞减少1.3%、中性粒细胞增多1.3%、白细胞增多1.3%、ALP升高1.3%"}, {"probability": {"variance": 0.001292, "average": 0.986283, "min": 0.838062}, "location": {"width": 840, "top": 923, "height": 39, "left": 249}, "words": "低钾血症1.3%、肌酸激酶升高1.3%;非血液学不良反应包括:腹泻3.8%、肠炎1.3%、呕吐1.3%"}, {"probability": {"variance": 0.001836, "average": 0.979956, "min": 0.840906}, "location": {"width": 271, "top": 975, "height": 26, "left": 250}, "words": "食欲下降2.5%、四肢水肿1.3%"}, {"probability": {"variance": 3e-06, "average": 0.998797, "min": 0.995634}, "location": {"width": 65, "top": 1018, "height": 25, "left": 250}, "words": "【禁忌】"}, {"probability": {"variance": 0.000144, "average": 0.995109, "min": 0.944331}, "location": {"width": 465, "top": 1053, "height": 33, "left": 250}, "words": "1.对替吉奥胶囊的组成成份有严重过敏史的患者禁用"}, {"probability": {"variance": 0.001056, "average": 0.984883, "min": 0.877024}, "location": {"width": 437, "top": 1094, "height": 33, "left": 249}, "words": "2.重度骨髓抑制的患者禁用(可能会加重骨髓抑制)"}, {"probability": {"variance": 0.006408, "average": 0.974627, "min": 0.491552}, "location": {"width": 857, "top": 1128, "height": 41, "left": 250}, "words": "3.重度肾功能异常的患者禁用[因5-氟尿嘧啶(5-FU)分解代谢酶抑制剂—吉美嘧啶经尿排泄明显"}, {"probability": {"variance": 0.003555, "average": 0.980132, "min": 0.642567}, "location": {"width": 819, "top": 1169, "height": 39, "left": 282}, "words": "降低时可能导致5-FU的血药浓度升高,从而加重骨髓抑制剂等不良反应(详见【药代动力学】)]。"}, {"probability": {"variance": 0.000428, "average": 0.993826, "min": 0.895081}, "location": {"width": 452, "top": 1215, "height": 33, "left": 284}, "words": "重度肝功能异常的患者禁用(可能会加重肝功能异常)"}, {"probability": {"variance": 0.000109, "average": 0.996512, "min": 0.932553}, "location": {"width": 810, "top": 1252, "height": 38, "left": 250}, "words": "5.正在接受其它氟尿嘧啶类抗肿瘤药治疗(包括联合治疗)的患者禁用(详见【药物相互作用】)"}, {"probability": {"variance": 0.010895, "average": 0.972629, "min": 0.423172}, "location": {"width": 543, "top": 1296, "height": 34, "left": 251}, "words": "6.正在接受氟胞嘧啶治疗的患者禁用(详见【药物相互作用】)"}, {"probability": {"variance": 0.000598, "average": 0.990683, "min": 0.856474}, "location": {"width": 754, "top": 1335, "height": 36, "left": 251}, "words": "7.正在接受索利夫定及其结构类似物(溴夫定)治疗的患者禁用(详见【药物相互作用】)"}, {"probability": {"variance": 0.000121, "average": 0.995985, "min": 0.937987}, "location": {"width": 584, "top": 1379, "height": 32, "left": 251}, "words": "8.妊娠或有可能妊娠的妇女禁用(详见【孕妇及哺乳期妇女用药】)"}, {"probability": {"variance": 0, "average": 0.999481, "min": 0.998578}, "location": {"width": 106, "top": 1426, "height": 25, "left": 250}, "words": "【注意事项】"}, {"probability": {"variance": 0.00047, "average": 0.988344, "min": 0.91719}, "location": {"width": 320, "top": 1465, "height": 27, "left": 251}, "words": "1.慎用[下列患者应慎用替吉奥胶囊]"}, {"probability": {"variance": 0.000157, "average": 0.993588, "min": 0.943205}, "location": {"width": 383, "top": 1503, "height": 32, "left": 291}, "words": "()有骨髓抑制的患者[可能会加重骨髓抑制]"}, {"probability": {"variance": 0.009472, "average": 0.968796, "min": 0.471873}, "location": {"width": 818, "top": 1539, "height": 40, "left": 291}, "words": "()肾功能异常的患者[因5-FU分解代谢酶抑制剂一吉美嘧啶经尿排泄明显降低时可能导致"}], "language": 3}